Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barrington Research Maintains Outperform on HealthEquity, Announces $100 Price Target

Author: Benzinga Newsdesk | March 22, 2024 11:10am
Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and announces $100 price target.

Posted In: HQY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist